¹øÈ£
Á¦¸ñ
ÀÛ¼ºÀÚ
¿Ã¸°³¯Â¥
´Ù¿î
Á¶È¸¼ö
À½¿ë¼ö¿¡ ´ëÇÑ Routing monitoring ¿ä±¸¿¡ ´ëÇÑ ´ëÀÀ ¹æÇâ ¸ð»ö
°ü¸®ÀÚ
2008-09-22
19
30
25
[±³À°¾È³»]ÀǾàǰ¹ë¸®µ¥À̼DZ³À°°úÁ¤-RA(¸®½ºÅ©ºÐ¼®)/URS(»ç¿ëÀڿ䱸 ±Ô°Ý¼)(06/23~24)
°ü¸®ÀÚ
2008-06-13
0
90
24
[±³À°¾È³»]ÀǾàǰ¹ë¸®µ¥À̼ǹ®¼È-VMP(¹ë¸®µ¥ÀÌ¼Ç Á¾ÇÕ°èȹ¼ ÀÛ¼º)(06/09~11)
°ü¸®ÀÚ
2008-06-09
0
81
23
»õ·Î¿î ǰÁú½Ã½ºÅÛÀÇ ±¸Ãà - ICH Q10
°ü¸®ÀÚ
2008-05-22
40
48
22
Áß±¹ ÇìÆÄ¸° °øÀå¿¡ ´ëÇÑ Á¶»ç ¹× warning letter
°ü¸®ÀÚ
2008-05-13
0
35
21
Merck warning letter
°ü¸®ÀÚ
2008-05-02
11
34
20
KFDA "ǰ¸ñº° »çÀü GMP Á¦µµ ¿î¿µÁöħ
°ü¸®ÀÚ
2008-04-28
10
22
19
»õGMPÇØ¼³¼_Á¦4°³Á¤
°ü¸®ÀÚ
2008-04-28
23
60
18
½Å¾à °øÁ¤ ¹ë¸®µ¥ÀÌ¼Ç ÀûÇÕ ÆÇÁ¤ '³ô¾Æ'
°ü¸®ÀÚ
2008-02-22
0
25
17
»õGMP±ÔÁ¤_Q&A(Up-date)
°ü¸®ÀÚ
2008-02-20
29
50
16
ÀǾàǰ µî »õ GMPÁ¦µµ ¼³¸íȸ(20080218)-3
°ü¸®ÀÚ
2008-02-20
10
26
15
ÀǾàǰ µî »õ GMPÁ¦µµ ¼³¸íȸ(20080218)-2
°ü¸®ÀÚ
2008-02-20
10
20
14
ÀǾàǰ µî »õ GMPÁ¦µµ ¼³¸íȸ(20080218)-1
°ü¸®ÀÚ
2008-02-20
14
35
13
º¹ÁöºÎ, ¿ÃÇØ ½Å¾à°³¹ß 510¾ï¿ø Áö¿ø
°ü¸®ÀÚ
2008-02-11
0
37
12
ÇÑ-EU FTA ÁöÀûÀç»ê±Ç ÀڷẸȣ 5³âÇÕÀÇ
°ü¸®ÀÚ
2008-02-11
0
29
11
°³Á¤ GMP ±âÁØ Áؼö öÀú ¿äû
°ü¸®ÀÚ
2008-02-01
12
40
10
ÀǾàǰµî ¹ë¸®µ¥ÀÌ¼Ç ½Ç½Ã¿¡ °üÇÑ ±ÔÁ¤(½Ä¾àû°í½Ã Á¦2008-5È£, 20080116)
°ü¸®ÀÚ
2008-01-17
16
65
9
¾à»ç¹ý½ÃÇà±ÔÄ¢ÀüºÎ°³Á¤·É(º¸°Çº¹ÁöºÎ·ÉÁ¦434È£)
°ü¸®ÀÚ
2008-01-17
12
64
8
½Ã¼³±âÁطɽÃÇà±ÔÄ¢ÀüºÎ°³Á¤·É(º¸°Çº¹ÁöºÎ·ÉÁ¦433È£)
°ü¸®ÀÚ
2008-01-17
18
72
7
GMP ±âÁØÀ» ±¹Á¦¼öÁØÀ¸·Î Àü¸é°³Á¤ ½ÃÇà¿¡ °ü·ÃÇÑ KFDA º¸µµÀÚ·á
°ü¸®ÀÚ
2008-01-17
15
36
1
[2]
À̸§
Á¦¸ñ
³»¿ë